Company Sector
Cancer Peptide Vaccines
Cancer Peptide Vaccines includes companies developing peptide-based therapeutic vaccines for oncology. These programs are designed to train the immune system against tumor-associated or tumor-specific antigens and are often paired with broader immunotherapy strategies.
Why watch Cancer Peptide Vaccines
This page combines a company index, a watch action, and the newest relevant feed items in one place so readers can monitor a biotech theme without scanning each company one by one.
Latest Cancer Peptide Vaccines news
The latest feed items from companies currently grouped under Cancer Peptide Vaccines.
- 01
- 02
PDSBPDS Biotech Announces up to $22.55 Million Financing Led by Dr. Patrick Soon-Shiong, Founder of NantWorks
Source: PDS Biotechnology Corporation
- 03
PDSBPDS Biotech Reports Second Quarter 2026 Financial Results
Source: PDS Biotechnology Corporation
- 04
PDSBPDS Biotech Announces Strategic Refocus Prioritizing PDS0301 in Metastatic Colorectal Cancer (mCRC) and Partnership Strategy for PDS0101
Source: PDS Biotechnology Corporation
- 05
GLSIGreenwich LifeSciences Extends Lock-up of Directors and Officers to January 31, 2027
Source: Greenwich LifeSciences
- 06
GLSIGreenwich LifeSciences Announces Approval to Expand FLAMINGO-01 into the United Kingdom
Source: Greenwich LifeSciences
- 07
GLSIGreenwich LifeSciences Provides Clinical Updates on FLAMINGO-01
Source: Greenwich LifeSciences
- 08
GLSIGreenwich LifeSciences Announces European Approval for Combining Both HLA Populations in FLAMINGO-01
Source: Greenwich LifeSciences
- 09
GLSIGreenwich LifeSciences Announces European Approval for Use of Commercially Manufactured GP2 in FLAMINGO-01
Source: Greenwich LifeSciences
- 10
GLSIGreenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at ASCO Meeting 2026
Source: Greenwich LifeSciences
- 11
GLSIGreenwich LifeSciences Provides Update Regarding Form 10-K Filing
Source: Greenwich LifeSciences
- 12
GLSIGreenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing
Source: Greenwich LifeSciences
- 13
PDSBPDS Biotech Reports First Quarter 2026 Financial Results and Provides Clinical Programs and Corporate Update
Source: PDS Biotechnology Corporation
- 14
PDSBPDS Biotech Announces Conference Call and Webcast for 2026 First Quarter Financial Results
Source: PDS Biotechnology Corporation
- 15
GLSIGreenwich LifeSciences Provides Update Regarding Form 10-K Filing
Source: Greenwich LifeSciences
- 16
GLSIGreenwich LifeSciences Announces Acceptance of Abstract at ASCO 2026
Source: Greenwich LifeSciences
- 17
GLSIGreenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing
Source: Greenwich LifeSciences
- 18
GLSIGreenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at AACR Meeting 2026
Source: Greenwich LifeSciences
- 19
- 20
GLSIGreenwich LifeSciences Provides Update on Financing Strategy
Source: Greenwich LifeSciences
Companies in Cancer Peptide Vaccines
2 companies tagged with Cancer Peptide Vaccines.
Frequently Asked Questions
What does the Cancer Peptide Vaccines sector include?
Cancer Peptide Vaccines includes companies developing peptide-based therapeutic vaccines for oncology. These programs are designed to train the immune system against tumor-associated or tumor-specific antigens and are often paired with broader immunotherapy strategies.
How many companies are currently tagged with Cancer Peptide Vaccines?
2 companies are currently grouped under Cancer Peptide Vaccines on BioPharmSignal.
Which companies are most visible in the Cancer Peptide Vaccines group right now?
GLSI, PDSB are among the companies currently shown on this sector page.
How can I watch news for Cancer Peptide Vaccines?
Use the Watch button on this page to subscribe to Cancer Peptide Vaccines headlines and related company updates through your BioPharmSignal saved filters.
What kinds of updates usually appear for Cancer Peptide Vaccines?
The livefeed typically surfaces company press releases, clinical readouts, FDA and regulatory updates, partnerships, financings, and commercialization developments tied to companies in Cancer Peptide Vaccines.